Lucira Health Applies for FDA Emergency Use Authorization for COVID-19, Flu Test; Shares Rise



MT Newswires 2023

All news about LUCIRA HEALTH, INC.

Analyst Recommendations on LUCIRA HEALTH, INC.

Sales 2022 186 M
–
–
Net income 2022 -154 M
–
–
Net Debt 2022 –
–
–
P/E ratio 2022 -0,48x
Yield 2022 –
Capitalization 4,51 M
4,51 M
–
Capi. / Sales 2022 0,02x
Capi. / Sales 2023 0,02x
Nbr of Employees 221
Free-Float 90,3%

Chart LUCIRA HEALTH, INC.



Duration :


Period :




Lucira Health, Inc. Technical Analysis Chart | MarketScreener

Technical analysis trends LUCIRA HEALTH, INC.

Short Term Mid-Term Long Term
Trends Bearish Bearish Bearish

Income Statement Evolution

Sell

Buy

Mean consensus UNDERPERFORM
Number of Analysts 2
Last Close Price 0,11 $
Average target price 0,75 $
Spread / Average Target 575%




Source link

Ozinize
Logo
Shopping cart